Paxlovid’s role in treating COVID-19 is not ending — it is evolving, according to the results of two national trials ...

Removes a Significant Uncertainty by Providing Pathway to U.S. Commercialization of Paxlovid on January 1, 2024 with Amended Supply Agreement In a Non-Cash Transaction, U.S. Government to Return ...

Add Yahoo as a preferred source to see more of our stories on Google. Doses of the COVID antiviral drug Paxlovid are displayed in New York on Aug. 1, 2022. (Stephanie Nano / Associated Press) The ...

Ducharme is a contributor to TIME. Pfizer's drug Paxlovid on display in Pembroke Pines, Fla., on July 7, 2022. Ducharme is a contributor to TIME. Taking the COVID-19 antiviral Paxlovid does not appear ...

A consensus has emerged among experts who study and treat long Covid: Paxlovid seems to reduce the risk of lingering symptoms among those eligible to take it. The idea is intuitive, experts say.

If you’ve tested positive for COVID-19, you might be wondering if it’s necessary to take an antiviral medication, such as Paxlovid. Pfizer’s Paxlovid (nirmatrelvir and ritonavir) gained full approval ...

WHEN YOU HAVE COVID and aren’t feeling well, you may worry about your symptoms getting worse and that you might end up in the hospital. One option that you have to potentially keep that from happening ...

BOSTON - Dr. Mallika Marshall is answering your latest health questions. If you have a question, email her or message her on Facebook or X (formerly known as Twitter). Sharon on Facebook writes, "I ...

The Biden administration will continue to manage the distribution of free courses of Pfizer's Paxlovid treatment for COVID-19 for at least another few months, the drugmaker said, even after the Food ...

The commercials make it sound so simple: "If it's COVID, Paxlovid." But the slogan, catchy though it may be, belies a harsher reality that some public health and elected officials have long ...

But the slogan, catchy though it may be, belies a harsher reality that some public health and elected officials have long acknowledged and worked to rectify: For many, getting access to the ...